Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Multifunctional Nanomaterials for Cancer Theranostics 277

263. Kulhari H, Pooja D, Shrivastava S, Telukutala SR, Barui AK, Patra CR,
     Naidu Vegi GM, Adams DJ, Sistla R. Cyclic­RGDfK peptide conju­
     gated succinoyl­TPGS nanomicelles for targeted delivery of docetaxel
     to integrin receptor over­expressing angiogenic tumours. Nanomedicine
     11 , 1511–1520 (2015).


264. Melemenidis S, Jefferson A, Ruparelia N, Akhtar AM, Xie J, Allen D,
     Hamilton A, Larkin JR, Perez­Balderas F, Smart SC, Muschel RJ,
     Chen X, Sibson NR, Choudhury RP. Molecular magnetic resonance
     imaging of angiogenesis in vivo using polyvalent cyclic RGD­iron
     oxide microparticle conjugates. Theranostics 5 , 515–529 (2015).


265. Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V,
     Freichels H, Jerome C, Marchand­Brynaert J, Feron O, Preat V.
     Targeting of tumor endothelium by RGD­grafted PLGA­nanoparticles
     loaded with paclitaxel. J. Control. Rel. 140 , 166–173 (2009).


266. Wang X, Li S, Shi Y, Chuan X, Li J, Zhong T, Zhang H, Dai W, He B,
     Zhang Q. The development of site­specific drug delivery nanocarriers
     based on receptor mediation. J. Control. Rel. 193 , 139–153 (2014).


267. Arosio D, Casagrande C. Advancement in integrin facilitated drug
     delivery. Adv. Drug Deliv. Rev. 97 , 111–143 (2016).


268. Luo G, Long J, Zhang B, Liu C, Ji S, Xu J, Yu X, Ni Q. Quantum dots
     in cancer therapy. Expert Opin. Drug Delivery 9 , 47–58 (2012).


269. Chi C, Du Y, Ye J, Kou D, Qiu J, Wang J, Tian J, Chen X. Intraoperative
     imaging­guided cancer surgery: from current fluorescence molecular
     imaging methods to future multi­modality imaging technology.
     Theranostics 4 , 1072–1084 (2014).


270. Li Y, Lin TY, Luo Y, Liu Q, Xiao W, Guo W, Lac D, Zhang H, Feng
     C, Wachsmann­Hogiu S, Walton JH, Cherry SR, Rowland DJ, Kukis
     D, Pan C, Lam KS. A smart and versatile theranostic nanomedicine
     platform based on nanoporphyrin. Nat. Commun. 5 , 4712 (2014).


271. Martelli C, Lo Dico A, Diceglie C, Lucignani G, Ottobrini L. Optical
     imaging probes in oncology. Oncotarget 7 , 48753–48787 (2016).


272. Kolodziej A, Krajewski W, Matuszewski M, Tupikowski K. Review of
     current optical diagnostic techniques for non­muscle­invasive bladder
     cancer. Cent. European J. Urol. 69 , 150–156 (2016).


273. Neefjes J, Dantuma NP. Fluorescent probes for proteolysis: Tools for
     drug discovery. Nat. Rev. Drug Discov. 3 , 58–69 (2004).


274. Kim JS, Quang DT. Calixarene­derived fluorescent probes. Chem. Rev.
     107 , 3780–3799 (2007).